Antiasthmatic and cough medication

Lee H. Goldstein*, Corinna Weber-Schöndorfer, Matitiahu Berkovitch

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

2 Scopus citations


Bronchial asthma affects pregnant women worldwide. During pregnancy asthma should be adequately treated for the benefit of the mother and the fetus, as severe, poorly treated asthma is associated with adverse perinatal outcomes. This chapter addresses the various medications used for asthma such as short- and long-acting beta agonists, inhaled and systemic corticosteroids, leukotriene modifiers, theophylline, mast cell stabilizers, anticholinergics and anti-IgE treatment. This chapter also addresses the use of mucolytics, expectorants and antitussive pharmacotherapy during pregnancy.

Original languageEnglish
Title of host publicationDrugs During Pregnancy and Lactation
Subtitle of host publicationTreatment Options and Risk Assessment: Third Edition
PublisherElsevier Inc.
Number of pages10
ISBN (Electronic)9780124079014
ISBN (Print)9780124080782
StatePublished - 2015


  • Anticholinergic
  • Antitussive
  • Asthma
  • Beta agonist
  • Corticosteroids
  • Cough
  • Expectorants
  • IgE
  • Leukotriene
  • Mast cell
  • Mucolytics


Dive into the research topics of 'Antiasthmatic and cough medication'. Together they form a unique fingerprint.

Cite this